Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca

</body> Date: Thursday May 15th Time: 4:00 pm GMT (UK) | 11:00 am EST PathXL’s proprietary tumor detection software, TissueMark®, has been evolving rapidly since its launch in November 2013 and we are glad to announce a range of...

Digital Pathology Workshop Wednesday, May 14, 2014 | 7 – 9 PM Wyndham Grand Pittsburgh Downtown | Grand Ballroom 1 The DPA will host a workshop at the Pathology Informatics Summit next week, providing participants with a broad and...

Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology Boulder, CO - April 30, 2014 - Flagship Biosciences announces it has reached agreement with Leica...

"We've been innovative to provide a much better pathology service for our patients. We're not going to stop there . . . our vision is that pathology really is the heart of a patient's diagnosis."   ​​– Dr. Sylvia...

Source: Dark Daily 7 May 2014 Prenatal testing, the most popular in China, is banned, affecting current projects at providers—another lesson for laboratories in how quickly things change Genetic testing has been halted in China. This...